Ocular late effects in childhood and adolescent cancer survivors: A report from the childhood cancer survivor study

Pediatric Blood and Cancer

Volumn 54, Issue 1, 2010, Pages 103-109

  Whelan, Kimberly F ^a   Stratton, Kayla ^b   Kawashima, Toana ^b   Waterbor, John W ^c   Castleberry, Robert P ^a   Stovall, Marilyn ^d   Sklar, Charles A ^e   Packer, Roger J ^f   Mitby, Pauline ^g   Aitken, Candice L ^h   Blatt, Julie ⁱ   Robison, Leslie L ^j   Mertens, Ann C ^k  

^a University of Alabama at Birmingham   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^g CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^h DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^k CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

more..

Author keywords

Chemotherapy; Late effects of cancer therapy; Radiation therapy

Indexed keywords

BUSULFAN; DEXAMETHASONE; PREDNISONE; GLUCOCORTICOID;

ADULT; ARTICLE; BLINDNESS; BRAIN RADIATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVOR; CATARACT; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIPLOPIA; DISEASE ASSOCIATION; DRUG EXPOSURE; DRY EYE; EYE DISEASE; FEMALE; GLAUCOMA; HEALTH; HODGKIN DISEASE; HUMAN; KIDNEY TUMOR; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; POSTERIOR FOSSA; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE; RETINA DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SIBLING; SOFT TISSUE SARCOMA; TEMPORAL LOBE; ADOLESCENT; CHILD; CLINICAL TRIAL; DRUG EFFECT; EYE; INFANT; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASM; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RADIATION INDUCED NEOPLASM; RADIATION INJURY; SURVIVAL RATE; SURVIVOR;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; EYE; EYE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; QUESTIONNAIRES; RADIATION INJURIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; YOUNG ADULT;

EID: 73349130796     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22277     Document Type: Article

References (32)

1. Linabery AM, Ross JA. Childhood and adolescent cancer survival in the U.S. by race and ethnicity for the diagnostic period 1975-1999. Cancer 2008;113:2575-2596.
2. Gatta G, Capocaccia R, Coleman MP, et al. Childhood cancer survival in Europe and the U.S. Cancer 2002;95:1767-1772.
3. Mertens AC, Liu Q, Neglia JP, et al. Cause-specific late mortality among 5 year survivors of childhood cancer: The Childhood Cancer Survivor Study. J Natl Cancer Inst 2008;100:1368-1379.
4. Ginsberg JP, Hobbie WL, Carlson CA, et al. Delivering long-term follow-up care to pediatric cancer survivors: Transitional care issues. Pediatr Blood Cancer 2006;46:169-173.
5. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006;355:1572-1582.
6. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics 2007;119:554-568.
7. HudsonMM, MertensAC,YasuiY, et al. Health status of adult long term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Am Med Assoc 2003;290:1583-1592.
8. Lackner H, Benesch M, Schagerl S, et al. Prospective evaluation of late effects of childhood cancer therapy with a follow-up over 9 years. Eur J Pediatr 2000;159:750-758.
9. Packer R, Gurney J, Punyko J, et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood Cancer Survivor Study. J Clin Oncol 2003;21: 3255-3261.
10. Friedman DL, Constine LS. Late effects of cancer treatment. In: Halperin EC, ConstineLS, Tarbell NJ, Kun LE, editors. Pediatric radiation oncology. Philadelphia, PA: Lippincott William & Wilkins; 2005. pp. 584-588.
11. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 2002;38: 229-239.
12. Stovall M, Weathers R, Kasper C, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: Use in epidemio-logical studies. Radiat Res 2006;166:141-157.
13. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, Inc.; 1987.
14. Taylor JMG, Munoz A, Bass SM, et al. Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Stat Med 1990;9:505-514.
15. Breslow NE, Daj NE. Statistical methods in cancer research: The design and analysis of cohort studies. New York, NY: Oxford University Press; 1994.
16. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
17. Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999;18:695-706.
18. Gurney JG, Ness KK, Rosenthal J, et al. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood. Cancer 2006; 106:1402-1408.
19. Kempen-Harteveld ML, Struikmans H, Kal HB, et al. Cataract-free interval and severity of cataract after total body irradiation and bone marrow transplantation: influence of treatment parameters. Int J Rad Oncol Biol Phys 2000;48:807-815.
20. Kempen-Harteveld ML, Struikmans H, Kal HB, et al. Cataract after total body irradiation and bone marrow transplantation: Degree of visual impairment. Int J Rad Oncol Biol Phys 2002;52:1375-1380.
21. Raney RB, Anderson JR, Kollath J, et al. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Med Pediatr Oncol 2000;34:413-420.
22. Bradfield YS, Kushner BJ, Gangon RE. Ocular complications after organ and bone marrow transplantation in children. J Am Assoc Pediatr Ophth Strabismus 2005;9:426-432.
23. Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: Results from the Bone Marrow Transplant Survivor Study. Blood 2004;104:1898-1906.
24. Jobling AI, Augusteyn RC. What causes steroid cataracts? A reviewof steroid-induced posterior subcapsular cataracts. Clin Exp Optom 2002;82:61-75.
25. James ER, Fresco VM, Robertson LL. Glucocorticoid-induced changes in the global gene expression of lens epithelial cells. J Ocular Pharm Ther 2005;21:11-27.
26. Beutel J, Schroder C, von Hof K, et al. Pharmacological prevention of radiation-induced dry eye - An experimental study in a rabbit model. Grafe's Arch Clin Exp Ophthalmol 2007;245:1347-1355.
27. Parsons JT. Response of the normal eye to high dose radiotherapy. Oncology 1996;10:837-847.
28. Parsons JT, Bova FJ, Fitzgerald CR, et al. Severe dry eye syndrome following external beam irradiation. Int J Rad Oncol Biol Phys 1994;30:775-780.
29. Phillips PH. Treatment of diplopia. Semin Neurol 2007;27:288-298.
30. MacRae SM, Rich LF, Macaluso DC. Treatment of interface keratitis with oral corticosteroids. J Cataract Refract Surg 2002;28: 454-461.
31. Mohan KC, Shukla D, Namperumalsamy P, et al. Management of age-related macular degeneration. J Indian Med Assoc 2003;101: 471-474.
32. Jain R, Kumar B. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy. J Dermatol 2003;30:713-718.